EyePoint Pharmaceuticals
EYPT
EYPT
141 hedge funds and large institutions have $649M invested in EyePoint Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
-10
Holders Change %
-6.62%
% of All Funds
1.89%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
21
Increased
51
Reduced
36
Closed
30
Calls
$2.85M
Puts
$11.4M
Net Calls
-$8.52M
Net Calls Change
-$8.77M
Top Buyers
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$7.53M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.65M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.84M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.21M |
| 5 |
SC
Stempoint Capital
New York
|
+$3.1M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$17.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12M |
| 3 |
PA
Perceptive Advisors
New York
|
-$8.33M |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$5.86M |
| 5 |
BlackRock
New York
|
-$3.4M |
